Literature DB >> 29066369

Astrocytic glutamatergic transporters are involved in Aβ-induced synaptic dysfunction.

Shuxuan Huang1, Huichun Tong2, Ming Lei3, Miaomiao Zhou1, Wenyuan Guo1, Guihua Li1, Xiaolu Tang1, Zhe Li1, Mingshu Mo1, Xiuping Zhang4, Xiang Chen1, Luan Cen1, Lei Wei5, Yousheng Xiao1, Kaiping Li6, Qinghui Huang7, Xinling Yang8, Weiguo Liu9, Li Zhang9, Shaogang Qu10, Shaomin Li11, Pingyi Xu12.   

Abstract

In Alzheimer's disease (AD), dementia severity correlates most strongly with decreased synapse density in the hippocampus and cerebral cortex. Although studies in rodents have established that hippocampal long-term potentiation (LTP) is inhibited by soluble oligomers of beta-amyloid (Aβ), the synaptic mechanisms remain unclear. Here, field excitatory postsynaptic potentials (fEPSP) recordings were made in the CA1 region of mouse hippocampal slices. The medium of APP-expressing CHO cells, which contain soluble forms of Aβ including small oligomers, inhibited LTP and facilitated long-term depression (LTD), thus making the LTP/LTD curve shift toward the right. This phenomenon could be mimicked by the non-selective glutamate transporter inhibitor, DL-TBOA. More specifically, the Aβ impaired LTP and facilitated LTD were occluded by the selective astrocytic glutamate transporter inhibitors, TFB-TBOA. In cultured astrocytes, the Aβ oligomers also decrease astrocytic glutamate transporters (EAAT1, EAAT2) expression. We conclude that soluble Aβ oligomers decrease the activation of astrocytic glutamate transporters, thereby impairing synaptic plasticity.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Astrocytes; Glutamate transporters; Long-term potentiation; Synaptic plasticity; TBOA

Mesh:

Substances:

Year:  2017        PMID: 29066369     DOI: 10.1016/j.brainres.2017.10.011

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

Review 1.  Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities.

Authors:  Shaomin Li; Andrew M Stern
Journal:  Mol Psychiatry       Date:  2022-04-28       Impact factor: 15.992

Review 2.  Function and therapeutic value of astrocytes in neurological diseases.

Authors:  Hong-Gyun Lee; Michael A Wheeler; Francisco J Quintana
Journal:  Nat Rev Drug Discov       Date:  2022-02-16       Impact factor: 112.288

Review 3.  Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability.

Authors:  Balázs Pál
Journal:  Cell Mol Life Sci       Date:  2018-05-15       Impact factor: 9.261

4.  Potential Mechanism of Cellular Uptake of the Excitotoxin Quinolinic Acid in Primary Human Neurons.

Authors:  Nady Braidy; Hayden Alicajic; David Pow; Jason Smith; Bat-Erdene Jugder; Bruce J Brew; Joseph A Nicolazzo; Gilles J Guillemin
Journal:  Mol Neurobiol       Date:  2020-09-06       Impact factor: 5.590

5.  Rapid homeostatic downregulation of LTP by extrasynaptic GluN2B receptors.

Authors:  Jary Y Delgado; Ann E Fink; Seth G N Grant; Thomas J O'Dell; Patricio Opazo
Journal:  J Neurophysiol       Date:  2018-08-15       Impact factor: 2.714

Review 6.  The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.

Authors:  Erika N Cline; Maíra Assunção Bicca; Kirsten L Viola; William L Klein
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 7.  Excitatory Amino Acid Transporters in Physiology and Disorders of the Central Nervous System.

Authors:  Anna R Malik; Thomas E Willnow
Journal:  Int J Mol Sci       Date:  2019-11-12       Impact factor: 5.923

8.  Amyloid Fibril-Induced Astrocytic Glutamate Transporter Disruption Contributes to Complement C1q-Mediated Microglial Pruning of Glutamatergic Synapses.

Authors:  Jiang Wu; Bihua Bie; Joseph F Foss; Mohamed Naguib
Journal:  Mol Neurobiol       Date:  2020-02-01       Impact factor: 5.590

Review 9.  Long-Term Impact of Early-Life Stress on Hippocampal Plasticity: Spotlight on Astrocytes.

Authors:  Gürsel Çalışkan; Anke Müller; Anne Albrecht
Journal:  Int J Mol Sci       Date:  2020-07-15       Impact factor: 5.923

Review 10.  Alzheimer's disease: targeting the glutamatergic system.

Authors:  Myra E Conway
Journal:  Biogerontology       Date:  2020-02-11       Impact factor: 4.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.